Background & Objective: Local relapse,tumor residue, and whole body metastases of nasopharyngeal carcinoma (NPC) after radiotherapy were mainly confirmed by CT, MRI, SPE/CT, and PET examinations. This study was to discuss the value of F-18-fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography (PET/CT) in detecting suspected recurrence or tumor residue, and whole body metastases of NPC after radiotherapy.
Methods: PET/CT were performed on 38 NPC patients 3-36 months after radiotherapy. The images of PET/CT, CT, and PET were observed. PET standardized uptake value (SUV) was calculated, and SUV of > 2.5 was considered as positive. The Patients were divided into 4 groups by diagnosis: (1) no recurrence/residue, and no whole body metastases; (2) with recurrence/residue, but no whole body metastases; (3) no recurrence/residue, but with whole body metastases; (4) with both recurrence/residue and whole body metastases. Diagnoses of all patients were referred to the proved follow-up clinical information. The following-up time was 6-10 months.
Results: The sensitivity, and specificity of PET/CT (100%,and 89.5%) were better than that of CT alone (77.8%, and 84.2%), a litter better than that of PET alone (100%, and 80.0%).
Conclusions: FDG-PET scan is a better tool than CT alone for the detection of recurrene or residue, and whole body metastases of NPC, a litter better than PET alone. PET/CT may provide valuable information for judging whether the focus is metastasis.
Download full-text PDF |
Source |
---|
Laryngoscope Investig Otolaryngol
February 2025
Division of Otolaryngology - Head and Neck Surgery, Department of Surgery Dalhousie University Halifax Nova Scotia Canada.
Objective: Carotid body tumors (CBTs) are rare neoplasms of the paraganglia at the carotid bifurcation. While typically benign, CBTs occasionally exhibit malignancy, metastasizing to nearby lymph nodes. Histopathologic analysis alone is insufficient to confirm malignancy, requiring metastases to non-neuroendocrine tissue for a definitive diagnosis.
View Article and Find Full Text PDFGlobal Spine J
January 2025
Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Study Design: Scoping review.
Objective: To identify which markers are used as surrogates for malnutrition in metastatic spine disease and which are the most studied outcomes associated with it.
Methods: A scoping review was performed by searching the PubMed/Medline, EMBASE, and Web of Science databases up to July 2022.
Exp Cell Res
January 2025
Department of Medical Engineering, Al-Nisour University College, Baghdad, Iraq.
The tumor microenvironment (TME) has drawn much interest recently in the search for innovative cancer therapeutics, especially in light of the growing body of evidence supporting the efficacy of immune checkpoint inhibitors (ICIs). The TME comprises various cell types within the extracellular matrix (ECM), such as immune cells, endothelial cells, and cancer-associated fibroblasts (CAFs). Throughout the malignancy, these cells interact with cancerous cells and with one another.
View Article and Find Full Text PDFJ Radiat Res
January 2025
Department of Radiation Oncology, Aichi Cancer Center Hospital, Chikusa-ku, Nagoya 464-8681, Japan.
This study aimed to evaluate the recent trends in single-fraction conventional radiotherapy (CRT) as palliative treatment in Japan, using data from the National Database published by the Ministry of Health, Labor, and Welfare. Data from fiscal year (FY) 2014 to FY2022, specifically related to the utilization of single-fraction CRT, were analyzed. Multi-fraction CRT, stereotactic body radiotherapy (SBRT), intensity-modulated radiotherapy (IMRT), and brachytherapy were excluded.
View Article and Find Full Text PDFLipids Health Dis
January 2025
Emergency surgery Dapartment (Trauma center), The First Affiliated Hospital, College of Clinical Medicine, Henan University of Science and Technology, Luoyang, 471003, Henan, China.
Lipid metabolism in cancer is characterized by dysregulated lipid regulation and utilization, critical for promoting tumor growth, survival, and resistance to therapy. Pancreatic cancer (PC) is a highly aggressive malignancy of the gastrointestinal tract that has a dismal 5-year survival rate of less than 10%. Given the essential function of the pancreas in digestion, cancer progression severely disrupts its function.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!